Clinical Trial: A Multicenter, Single-Arm, Prospective Phase II Clinical Study of Trastuzumab Rezetecan Combined With Radiotherapy in Patients With HER2-Mutated Oligoprogressive Advanced Non-Small Cell Lung Cancer

U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07781202) titled 'A Multicenter, Single-Arm, Prospective Phase II Clinical Study of Trastuzumab Rezetecan Combined With Radiotherapy in Patients With HER2-Mutated Oligoprogressive Advanced Non-Small Cell Lung Cancer' on Aug. 17.

Brief Summary: A Multicenter, Single-Arm, Prospective Phase II Clinical Study of Trastuzumab Rezetecan Combined with Radiotherapy in Patients with HER2-Mutated Oligoprogressive Advanced Non-Small Cell Lung Cancer

Study Start Date: Aug. 30

Study Type: INTERVENTIONAL

Condition: HER2-mutated Advanced Non-small Cell Lung Cancer With Oligoprogression

Intervention: DRUG: Trastuzumab Rezetecan combined with radiotherapy

Trast...